MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

GSK503

CAS No. : 1346572-63-1

MCE 站：GSK503

产品活性：GSK503是高效特异性的EZH2甲基转移酶抑制剂，K_i^app值为3到27 nM。

研究领域：Epigenetics

作用靶点：Histone Methyltransferase

In Vitro: GSK503 inhibits the methyltransferase activity of wild type ａnd mutant EZH2 with similar potency (K_i^app=3-27 nM) ａnd is structurally related to GSK126 ａnd GSK343. GSK503 is >200 fold selective over EZH1 (K_i^app=636 nM) ａnd >4000 fold selective over other histone methyltransferases.

In Vivo: In a melanoma mouse model, conditional EZH2 ablation as much as treatment with the GSK503 stabilizes the disease through inhibition of growth ａnd virtually abolishes metastases formation without affecting normal melanocyte biology. GSK503 displays favorable pharmacokinetics in mice. GSK503, but not vehicle, prevents the formation of germinal center after SRBC or NP-KLH immunization, phenocopying the Ezh2 null phenotype. GSK503 treatment leads to reduced numbers of GC B-cells by flow cytometry, reduces number ａnd volume of GCs by immunohistochemistry, ａnd impairs formation high affinity antibodies.

相关产品：Bioactive Compound Library Plus  |  Epigenetics Compound Library  |  Histone Modification Research Compound Library  |  Anti-Cancer Compound Library  |  Reprogramming Compound Library  |  Anti-Blood Cancer Compound Library  |  Tazemetostat  |  GSK126  |  GSK3326595  |  Pinometostat  |  3-Deazaneplanocin A hydrochloride  |  GSK3368715 dihydrochloride  |  GSK343  |  JNJ-64619178  |  EPZ015666  |  EED226  |  UNC0642  |  UNC1999  |  Chaetocin  |  MS023  |  EZM 2302  |  BIX-01294  |  EPZ020411 hydrochloride  |  UNC0638  |  EPZ031686  |  OICR-9429  |  LLY-283  |  SGC0946  |  A-366  |  CM-272  |  MM-102 TFA  |  Amodiaquine dihydrochloride dihydrate  |  EPZ004777  |  PFI-2 hydrochloride  |  GSK591

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。